Genomic landscape and clinical features of rare subtypes of pancreatic cancer: analysis with the national database of Japan
Journal of Gastroenterology · 2023-06 · 58 (6) · 575-585
DOI: 10.1007/s00535-023-01986-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology, 2023-06. Verfasst von Tomoki Sakakida und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, 465 Kajiicho, Hirokoji Agaru, Kawaramachi Street, …. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Special subtypes of pancreatic cancer, such as acinar cell carcinoma (ACC), adenosquamous carcinoma (ASC), and anaplastic carcinoma of the pancreas (ACP), are rare, and so data on them are limited. Using the C-CAT database, we analyzed clinical and genomic characteristics of patients with these and evaluated differences on comparison with pancreatic ductal adenocarcinoma (PDAC) patients.
Methods
We retrospectively reviewed data on 2691 patients with unresectable pancreatic cancer: ACC, ASC, ACP, and PDAC, entered into C-CAT from June 2019 to December 2021. The clinical features, MSI/TMB status, genomic alterations, overall response rate (ORR), disease control rate (DCR), and time to treatment failure (TTF) on receiving FOLFIRINOX (FFX) or GEM + nab-PTX (GnP) therapy as first-line treatment were evaluated.
Results
Numbers of patients with ACC, ASC, ACP, and PDAC were 44 (1.6%), 54 (2.0%), 25 (0.9%), and 2,568 (95.4%), respectively. KRAS and TP53 mutations were prevalent in ASC, ACP, and PDAC (90.7/85.2, 76.0/68.0, and 85.1/69.1%, respectively), while their rates were both significantly lower in ACC (13.6/15.9%, respectively). Conversely, the rate of homologous recombination-related (HRR) genes, including ATM and BRCA1/2, was significantly higher in ACC (11.4/15.9%) than PDAC (2.5/3.7%). In ASC and ACP, no significant differences in ORR, DCR, or TTF between FFX and GnP were noted, while ACC patients showed a trend toward higher ORR with FFX than GnP (61.5 vs. 23.5%, p = 0.06) and significantly more favorable TTF (median 42.3 vs. 21.0 weeks, respectively, p = 0.004).
Conclusions
ACC clearly harbors different genomics compared with PDAC, possibly accounting for differences in treatment efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, 465 Kajiicho, Hirokoji Agaru, Kawaramachi Street, Kamigyoku, Kyoto City, Kyoto, 602-8566, Japan.
- Department of Cancer Genome Medical Center, Kyoto Prefectural University of Medicine, Kyoto, Japan.
- Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, 465 Kajiicho, Hirokoji Agaru, Kawaramachi Street, Kamigyoku, Kyoto City, Kyoto, 602-8566, Japan. iskw-t@koto.kpu-m.ac.jp.
- Department of Cancer Genome Medical Center, Kyoto Prefectural University of Medicine, Kyoto, Japan. iskw-t@koto.kpu-m.ac.jp.
- Outpatient Oncology Unit, Kyoto Prefectural University of Medicine, Kyoto, Japan. iskw-t@koto.kpu-m.ac.jp.
- Outpatient Oncology Unit, Kyoto Prefectural University of Medicine, Kyoto, Japan.
ORCID-Profile: Tomoki Sakakida
Zitieren
APA
Sakakida, T., Ishikawa, T., Doi, T., Morita, R., Kataoka, S., Miyake, H., Yamaguchi, K., Moriguchi, M., Sogame, Y., Yasuda, H., Iwasaku, M., Konishi, H., Takayama, K., & Itoh, Y. (2023). Genomic landscape and clinical features of rare subtypes of pancreatic cancer: analysis with the national database of Japan. Journal of Gastroenterology. https://doi.org/10.1007/s00535-023-01986-9
Vancouver
Sakakida T, Ishikawa T, Doi T, Morita R, Kataoka S, Miyake H, et al. Genomic landscape and clinical features of rare subtypes of pancreatic cancer: analysis with the national database of Japan. Journal of Gastroenterology. 2023. doi:10.1007/s00535-023-01986-9
BibTeX
@article{Sakakida2023,
author = {Sakakida, Tomoki and Ishikawa, Takeshi and Doi, Toshifumi and Morita, Ryuichi and Kataoka, Seita and Miyake, Hayato and Yamaguchi, Kanji and Moriguchi, Michihisa and Sogame, Yoshio and Yasuda, Hiroaki and Iwasaku, Masahiro and Konishi, Hideyuki and Takayama, Koichi and Itoh, Yoshito},
title = {Genomic landscape and clinical features of rare subtypes of pancreatic cancer: analysis with the national database of Japan},
journal = {Journal of Gastroenterology},
year = {2023},
doi = {10.1007/s00535-023-01986-9}
}
EUVIMED